| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075316 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmai agents; anticancer agents; astaxanthin |
| 04/07/2005 | US20050072962 Contains phenoxazine or phenothiazine dye; absorption coefficient, sharp hue, solubility |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/06/2005 | CN1195759C Process for preparation of benzoxazine derivatives and intermediates therefor |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 03/31/2005 | WO2005028455A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 03/31/2005 | US20050070707 [1.2]-Oxazin-3,5-diones |
| 03/30/2005 | EP1517894A1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 03/30/2005 | EP1235831B1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/29/2005 | US6872823 Bactericides; chemical intermediates |
| 03/24/2005 | WO2005026135A1 Method for the production of 4-(4-aminophenyl)-3-morpholinon |
| 03/24/2005 | US20050065097 Liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 03/24/2005 | US20050065096 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515958A2 Process for the synthesis of mosapride |
| 03/23/2005 | EP1515931A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media |
| 03/23/2005 | EP1515724A1 Mitotic kinesin inhibitors |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/17/2005 | WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2 |
| 03/17/2005 | WO2005023755A1 Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 03/17/2005 | WO2004089920A3 Amine-substituted diphenyldiphosphines and the use thereof in metal complexes for asymmetric syntheses |
| 03/17/2005 | US20050059824 Using carbon dioxide; salt formation, hydrolysis |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/17/2005 | US20050059659 Carotenoid analogs or derivatives for controlling C-reactive protein levels |
| 03/17/2005 | US20050059635 Astaxanthin, beta-carotene, zeanthin, canthaxanthin |
| 03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
| 03/15/2005 | US6867204 Benzoxazine derivatives and uses thereof |
| 03/15/2005 | CA2086914C Quinolone-and naphthyridone-carboxylic acid derivatives |
| 03/10/2005 | WO2005021605A1 Process for the preparation of a functionalized polymer, intermediate products, processes for the preparation thereof, a functionalized polymer and polymer composition containing a functionalized polymer and shaped parts |
| 03/10/2005 | WO2004096795A3 C-fms kinase inhibitors |
| 03/10/2005 | US20050054668 Antagonists of MCP-1 function and methods of use thereof |
| 03/09/2005 | EP1512397A1 O-substituted hydroxyaryl derivatives |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/03/2005 | WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | US20050049286 Cardiovascular homeostasis through combination of direct neuronal control and systemic neurohormonal activation |
| 03/03/2005 | US20050049248 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility; cancer, rheumatoid arthritis, stroke, cardiovascular inflammation |
| 03/02/2005 | EP1510532A1 Process for the preparation of a functionalized polymer, intermediate products, processes for the preparation thereof, a functionalized polymer and polymer composition containing a functionalized polymer and shaped parts |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 03/02/2005 | EP1509508A1 Selective chromophores |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1589272A Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1191242C Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1, 4-dihydro-2H-3, 1-benzoxazine-2-ketone |
| 03/01/2005 | US6861416 New intermediates and synthetic methods for the stereospecific synthesis of oxazinone compounds, which are useful, for example, as antibiotics. The invention also pertains to novel olefinic oxazinone compounds, methods for |
| 02/24/2005 | WO2005016899A1 Method for production of n-aryl morpholinones |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2004112688A3 7-alkyloxy-2h-1,4-benzoxacin-3(4h)-one derivatives and preparation method thereof |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/22/2005 | US6858727 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/17/2005 | WO2005014515A2 Clear photopolymerizable systems for the preparation of high thickness coatings |
| 02/17/2005 | WO2004016578A8 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/17/2005 | US20050037995 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 02/16/2005 | EP1506196A2 Pyrazolopyrimidines |
| 02/16/2005 | EP1506179A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 02/16/2005 | EP0944610B1 Asymmetric synthesis of benzoxazinones |
| 02/16/2005 | CN1580037A Symmetrical fluorene derivatives with multi proton absorption |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855674 Hydroxy aromatic Mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions |
| 02/10/2005 | WO2004113362A3 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 02/10/2005 | US20050032795 2-Amino-benzoxazinones for the treatment of herpes simplex virus |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032793 For example, 1,1-dimethylethyl [2-[[2-(diethylamino)-2-oxo-1S-(phenylmethyl)ethyl]amino]-5-methyl-4-oxo-4H-3,1-benzoxazin-6-yl]carbamate; for treating herpes-related disorders |
| 02/10/2005 | US20050028953 In bleaching plant; catalytic oxidation of pulp slurry, washing, stabilization |
| 02/09/2005 | EP1505199A1 Methods for making carboxylated pulp fibers |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP0941093B1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/08/2005 | US6852865 Epoxides, aziridines, thiiranes, oxetanes, lactones, lactams and analogous compounds are reacted with carbon monoxide in the presence of a catalytically effective amount of catalyst complex of transition metal carbonyl and Lewis acid |
| 02/05/2005 | CA2475665A1 Methods for making carboxylated pulp fibers |
| 02/03/2005 | WO2004087940A3 PROCESS FOR PRODUCING ENANTIOPURE β-AMINO ACID DERIVATIVES, AND ENANTIOPURE β-AMINO ACID DERIVATIVES |
| 02/03/2005 | US20050027120 Method for the synthesis of amides and related products from esters or ester-like compounds |
| 02/03/2005 | US20050027119 Methyl (2S)-2-(2,3,4-trifluoroanilino)propionate from 2,3,4-trifluoroaniline and an acetic acid ester in the presence of a metal catalyst under a hydrogen gas; antibacterial agents |
| 02/03/2005 | US20050026874 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility |
| 02/03/2005 | DE10329295A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1175390B1 Disodium salts, monohydrates, and ethanol solvates |
| 02/02/2005 | CN1573599A Novel charge transport materials having heteroaromatic hydrazone groups |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/26/2005 | EP1499611A1 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1436335B1 Method for crosslinking hydrogels with morpholine-2,3-diones |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0920423B1 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 01/26/2005 | CN1186333C 1-(alpha-aminobenzyl)-2 naphthol ketal (acetal) compound and its preparation and use |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |